Drexler H G, Sperling C, Ludwig W D
German Collection of Microorganisms and Cell Cultures, Braunschweig.
Leukemia. 1993 Aug;7(8):1142-50.
Terminal deoxynucleotidyl transferase (TdT) was initially considered as a marker of immature lymphoid cells, but many studies have since provided conclusive evidence for the existence of TdT+ cases of acute myeloid leukemia (AML). The reported incidence of TdT+ AML cases varies largely (from 0% to 55%, average of combined data of the literature 18%, children 19%, and adults 21%) suggesting interlaboratory differences in the types of AML examined, the sensitivity of the method used, and the percentage of positive blasts taken as cut-off value. Significantly higher frequencies of TdT+ AML were reported in studies employing immunocytochemical staining (alkaline phosphatase anti-alkaline phosphatase or immunoperoxidase) than in series using immunofluorescence microscopy or biochemical assays. Statistical analysis of various cut-off levels demonstrates an inverse correlation between cut-off point and incidence. The combined data show that TdT-positivity is more common in the immature cell types (M0, M1), with no correlation with age or sex. Except for contested suggestions of an association with t(6;9) and t(8;21), no clear relationship between karyotype and TdT status has been documented. Although an association between T-cell receptor or immunoglobulin gene rearrangements and expression of TdT in AML was postulated, subsequent studies could not demonstrate this correlation. There was no significant relationship with other immunophenotypic markers except for CD34 positivity suggesting that the TdT+ cells represent an immature population. The percentage of positive cells was usually lower in AML than in ALL; in most cases only a subpopulation of the AML cells was TdT+. Thus, TdT could be viewed as a marker of hematopoietic immaturity. In about one-half of the studies on adults, TdT expression was reported to indicate a poor prognosis; others did not find any prognostic difference between TdT+ and TdT- AML cases. No correlation between TdT-positivity and prognosis was found in childhood AML.
末端脱氧核苷酸转移酶(TdT)最初被认为是未成熟淋巴细胞的标志物,但此后许多研究为急性髓系白血病(AML)中TdT阳性病例的存在提供了确凿证据。报道的TdT阳性AML病例的发生率差异很大(从0%到55%,文献综合数据的平均值为18%,儿童为19%,成人为21%),这表明在检查的AML类型、所用方法的敏感性以及作为临界值的阳性原始细胞百分比方面存在实验室间差异。与使用免疫荧光显微镜或生化检测的系列研究相比,采用免疫细胞化学染色(碱性磷酸酶抗碱性磷酸酶或免疫过氧化物酶)的研究报道的TdT阳性AML频率显著更高。对各种临界水平的统计分析表明临界值与发生率呈负相关。综合数据显示,TdT阳性在未成熟细胞类型(M0、M1)中更常见,与年龄或性别无关。除了关于与t(6;9)和t(8;21)相关的有争议的建议外,核型与TdT状态之间没有明确的关系记录。尽管有人推测T细胞受体或免疫球蛋白基因重排与AML中TdT的表达有关,但随后的研究未能证实这种相关性。除了CD34阳性外,与其他免疫表型标志物没有显著关系,这表明TdT阳性细胞代表一个未成熟群体。AML中阳性细胞的百分比通常低于ALL;在大多数情况下,只有一部分AML细胞是TdT阳性。因此,TdT可被视为造血未成熟的标志物。在约一半关于成人的研究中,TdT表达被报道表明预后不良;其他研究未发现TdT阳性和TdT阴性AML病例之间存在任何预后差异。在儿童AML中未发现TdT阳性与预后之间的相关性。